m6A modification-mediated LINC01547 promotes pancreatic cancer growth and gemcitabine sensitivity through miR-34a-5p/MYH9 axis
Guo‐Dong Lu(Guangxi Medical University), Jun Hu(Yichang Central People's Hospital)
Cited by 0
Related Papers
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
|Acta Pharmacologica Sinica|2020|300
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
|Acta Pharmacologica Sinica|2020|161
Fatty acid activation in carcinogenesis and cancer development: Essential roles of long‑chain acyl‑CoA synthetases (Review)
|Oncology Letters|2018|154
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy
|Experimental & Molecular Medicine|2022|35
Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8+ T cell activation
|Molecular Therapy Oncology|2024|5